Application validation of a novel nucleic acid encapsulation process (RNA, ASO, etc.)

Description

Description of the proposed partnership project: This project aims to qualify and validate the performance of an instrument for manufacturing lipid nanoparticles (LNPs) for RNA encapsulation, in a GLP to GMP-like setting. Performance criteria mainly cover the physicochemical characteristics of the LNPs and their therapeutic efficacy in vitro and in vivo. Target participants: Nanomedicine or non-viral gene therapy manufacturing sites; CDMOs specialised in formulation or in quality control of (non-viral) nanomedicine batches. Added value for participants: Access to the innovative equipment throughout the collaboration. Added value for the project lead: Optimisation of the proprietary technology and user feedback on the equipment developed. Contact: Audrey Nsamela, +33 7 67 60 10 08, audrey.nsamela@insidetx.com

Presented by